Synthesis of tobacco-derived cembratriene-ol and cembratriene-diol in yeast using engineered enzymes
Abstract Background: Cembranoids are one kind of diterpenoids with multiple biological activities, and the tobacco cembatriene-ol (CBT-ol) and cembatriene-diol (CBT-diol) have high anti-insect and anti-fungal activities, which is attracting great attention for their potential usage in sustainable agriculture. Cembranoids have been supposed to be formed through the 2-C-methyl-D-erythritol-4- phosphate (MEP) pathway, yet the involvement of mevalonate (MVA) pathway in their synthesis remains unclear. Exploring the roles of MVA pathway in cembranoid synthesis could contribute not only to the technical approach but also to the molecular mechanismfor cembranoid biosynthesis. Results: We constructed a vector to express an engineered protein fusion of cembranol synthase (CBTS1) and the GAL4 AD domain as a N-terminal translation leader. Eventually, the engineered enzyme AD-CTBS1 was successfully expressed, which further resulted in the production of CBT-ol in yeast with an optimized MVA pathway for geranyl-geranyl diphosphate (GGPP) production, but not in other yeast strains with low GGPP supply. Subsequently, CBT-diol was also synthesized by co-expression of engine-ered cembranol synthase (CBTS1) and cytochrome P450 hydroxylase (CYP450) in the yeast enhanced MVA pathway. Conclusions: We demonstrated that yeast could be applied to the production of tobacco-derived CBT-ol and CBT-diol, which are anti-fungal compounds. And, established a new way to produce the tobacco-derived CBT-ol and CBT-diol in yeast with optimized MVA pathway for GGPP production. Thus, this study established a feasibility for cembranoid production via the MVA pathway and provided an alternative bio-approach for the production of cembranoids in microbes.